These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10231401)

  • 1. Molecular genetic analysis of non-astrocytic gliomas.
    Tong CY; Ng HK; Pang JC; Hui AB; Ko HC; Lee JC
    Histopathology; 1999 Apr; 34(4):331-41. PubMed ID: 10231401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
    Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
    Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of molecular alterations in microdissected archival gliomas.
    Walker C; Joyce KA; Thompson-Hehir J; Davies MP; Gibbs FE; Halliwell N; Lloyd BH; Machell Y; Roebuck MM; Salisbury J; Sibson DR; Du Plessis D; Broome J; Rossi ML
    Acta Neuropathol; 2001 Apr; 101(4):321-33. PubMed ID: 11355303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of the PTEN gene in gliomas: molecular and pathological correlations.
    Zhou XP; Li YJ; Hoang-Xuan K; Laurent-Puig P; Mokhtari K; Longy M; Sanson M; Delattre JY; Thomas G; Hamelin R
    Int J Cancer; 1999 Apr; 84(2):150-4. PubMed ID: 10096247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of p53 and PTEN gene mutations in gliomas.
    Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
    Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice.
    Leuraud P; Taillandier L; Aguirre-Cruz L; Medioni J; Crinière E; Marie Y; Dutrillaux AM; Kujas M; Duprez A; Delattre JY; Poupon MF; Sanson M
    Br J Cancer; 2003 Dec; 89(12):2327-32. PubMed ID: 14676814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
    Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
    Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.
    Fujisawa H; Kurrer M; Reis RM; Yonekawa Y; Kleihues P; Ohgaki H
    Am J Pathol; 1999 Aug; 155(2):387-94. PubMed ID: 10433932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of non-astrocytic gliomas.
    Al-Sarraj ST
    Histopathology; 1999 Apr; 34(4):370-1. PubMed ID: 10231405
    [No Abstract]   [Full Text] [Related]  

  • 11. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
    Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
    Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p.
    Reifenberger J; Reifenberger G; Liu L; James CD; Wechsler W; Collins VP
    Am J Pathol; 1994 Nov; 145(5):1175-90. PubMed ID: 7977648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization.
    Bigner SH; Matthews MR; Rasheed BK; Wiltshire RN; Friedman HS; Friedman AH; Stenzel TT; Dawes DM; McLendon RE; Bigner DD
    Am J Pathol; 1999 Aug; 155(2):375-86. PubMed ID: 10433931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the PTEN/MMAC1 gene in archival low grade and high grade gliomas.
    Davies MP; Gibbs FE; Halliwell N; Joyce KA; Roebuck MM; Rossi ML; Salisbury J; Sibson DR; Tacconi L; Walker C
    Br J Cancer; 1999 Mar; 79(9-10):1542-8. PubMed ID: 10188904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of molecular genetic analysis of p53, MDM2, p16, PTEN, and EGFR and survival of patients with anaplastic astrocytoma and glioblastoma.
    Ushio Y; Tada K; Shiraishi S; Kamiryo T; Shinojima N; Kochi M; Saya H
    Front Biosci; 2003 May; 8():e281-8. PubMed ID: 12700122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 gene mutation and ink4a-arf deletion appear to be two mutually exclusive events in human glioblastoma.
    Fulci G; Labuhn M; Maier D; Lachat Y; Hausmann O; Hegi ME; Janzer RC; Merlo A; Van Meir EG
    Oncogene; 2000 Aug; 19(33):3816-22. PubMed ID: 10949938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
    Kraus JA; Felsberg J; Tonn JC; Reifenberger G; Pietsch T
    Neuropathol Appl Neurobiol; 2002 Aug; 28(4):325-33. PubMed ID: 12175345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma?
    Rustia A; Wierzbicki V; Marrocco L; Tossini A; Zamponi C; Lista F
    Neurosurg Rev; 2001 Jul; 24(2-3):97-102. PubMed ID: 11485247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis.
    Sasaki H; Zlatescu MC; Betensky RA; Ino Y; Cairncross JG; Louis DN
    Am J Pathol; 2001 Jul; 159(1):359-67. PubMed ID: 11438483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.